| 791 |
CORTICAL NEURONAL EXCITABILITY AND TRANSCALLOSAL INHIBITION IN SCHIZOPHRENIC PATIENTS; TRANSCRANIAL MAGNETIC STUDY |
2006 |
| 792 |
CORTICAL NEURONAL EXCITABILITY AND TRANSCALLOSAL INHIBITION IN SCHIZOPHRENIC PATIENTS; TRANSCRANIAL MAGNETIC STUDY |
2006 |
| 793 |
CORTICAL NEURONAL EXCITABILITY AND TRANSCALLOSAL INHIBITION IN SCHIZOPHRENIC PATIENTS; TRANSCRANIAL MAGNETIC STUDY |
2006 |
| 794 |
CORTICAL NEURONAL EXCITABILITY AND TRANSCALLOSAL INHIBITION IN SCHIZOPHRENIC PATIENTS; TRANSCRANIAL MAGNETIC STUDY |
2006 |
| 795 |
Cranial and peripheral neuropathy in rheumatoid arthritis with special emphasis toII, V, VII and XI cranial nerves. |
2006 |
| 796 |
Cranial Neuropathy in Rheumatoid arthritis with special emphasis to II, V, VII, VIII and XI cranial nerves. |
2006 |
| 797 |
Drug evaluation: PTC-124 - a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. |
2006 |
| 798 |
Epidemiology of Cerebrovascular Stroke and TIA in Upper Egypt (Sohag)–Relative Frequency of Stroke in Assiut University Hospital. |
2006 |
| 799 |
Intravitreal Triamcinolone in Treatment of Diffuse Diabetic Macular Oedema: Functional and Anatomic Evaluation. |
2006 |
| 800 |
Irreversible cochlear damage in myasthenia gravis-otoacoustic emission analysis |
2006 |
هل لديك سؤال ؟
